GBI Research

GBI Research provides industry-leading global business intelligence solutions. Our products and services help companies make better business decisions, win business and position themselves more effectively. GBI Research publishes more than 100 research reports per annum across a wide range of industries. Our reports draw on in-depth primary and secondary research, databases of proprietary in-house data and high quality analysis from our expert teams. GBI Research employs hundreds of highly qualified Analysts across the US, Europe and Asia. Key report types currently published by GBI Research i
nclude:

  • Market Intelligence Reports: premium analytical reports based on a combination of market data, company, deals and project content, industry surveys and additional primary and secondary research.
  • Benchmarking Reports: analytical reports comparing key financial indicators for the top 20 companies in a particular industry and geography.
  • Industry Outlook Reports: survey-based reports, revealing and analyzing the leading experts' opinions on the future of the industry covered.
  • Market Profiles: overview-level reports based on market, company and demographic data.
  • Pipeline Analysis Reports: reports analyzing the unmet need, market size and product pipeline for different disease indications, based on a detailed database of developmental products.
GBI Research
 

List of reports from GBI Research

2  3  4  5    7    9  10  11  
Pharmaceutical Supply Chain in Japan - Periodic Drug Price Revisions by National Health Insurance Increase Competition and Squeeze Profit Margins
8/6/2012 | published by: GBI Research
... Supply Chain in Japan - Periodic Drug Price Revisions by National Health Insurance Increase Competition and Squeeze Profit Margins”. The report focuses on the current scenario of supply chain management. Key participants in the pharmaceutical ...  |  read more...
USD 3,500
Hospital Supplies Market to 2018 - Increasing Preference for Electro-mechanical Tables over Conventional Hydraulic Models to Drive Market Growth
7/31/2012 | published by: GBI Research
... Conventional Hydraulic Models to Drive Market Growth” provides key data, information and analysis on the global hospital supplies market. The report provides a market landscape, competitive landscape and market trends information on the six hospital ...  |  read more...
USD 3,500
Endoscopy Devices Market to 2018 - Demand for Cost-Effective, Minimally Invasive Procedures and Reimbursement for New Indications to Increase Uptake
7/31/2012 | published by: GBI Research
... Procedures and Reimbursement for New Indications to Increase Uptake” provides key data, information and analysis on the global endoscopy devices market. The report provides a market landscape, competitive landscape and market trends information on the ...  |  read more...
USD 3,500
Neurostimulation Devices Market to 2018 - Technological Advances and Robust Pipeline with Multi-Indication Potential and Non-Invasive Therapies to Drive Growth
7/31/2012 | published by: GBI Research
... with Multi-Indication Potential and Non-Invasive Therapies to Drive Growth”, provides key data, information and analysis on the global neurostimulation devices market. The report provides the market landscape, competitive landscape and market trend information on five ...  |  read more...
USD 3,500
Sales Force Effectiveness in Pharmaceuticals - Targeted Sales Models such as Enhanced Key Account Management (KAM) and Closed-Loop Marketing (CLM) Strategies Drives Sales Force Efficiency
7/31/2012 | published by: GBI Research
... latest research report, entitled “Sales Force Effectiveness in Pharmaceuticals - Targeted Sales Models such as Enhanced Key Account Management (KAM) and Closed-Loop Marketing (CLM) Strategies Drives Sales Force Efficiency”. The report provides key data, information ...  |  read more...
USD 3,500
e-Clinical Trial Solutions Market to 2018 - Growing Complexity of Clinical Trials and Increased Focus on Accuracy and Efficiency Drive Trial Sponsors to Adopt Novel Technologies
7/31/2012 | published by: GBI Research
... released its latest research, “e-Clinical Trial Solutions Market to 2018 - Growing Complexity of Clinical Trials and Increased Focus on Accuracy and Efficiency Drive Trial Sponsors to Adopt Novel Technologies”, which provides key data and ...  |  read more...
USD 3,500
Epigenetics R&D Pipeline - Histone Deacetylases (HDACs) Offer the Most Promising Targets and Outnumber Other Classes of Epigenetic Targets
7/31/2012 | published by: GBI Research
... Pipeline - Histone Deacetylases (HDACs) Offer the Most Promising Targets and Outnumber Other Classes of Epigenetic Targets”. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house ...  |  read more...
USD 3,500
Active Pharmaceutical Ingredients (API) Market in Europe to 2017 - Pricing and Reimbursement Initiatives Supporting Generic Drug Growth, with CMOs Expected to Account for Majority of the Manufacturing Activity
7/10/2012 | published by: GBI Research
... Ingredients (API) Market in Europe to 2017 - Pricing and Reimbursement Initiatives Supporting Generic Drug Growth, with CMOs Expected to Account for Majority of the Manufacturing Activity” provides detailed insight into the Europe API market. ...  |  read more...
USD 3,500
Pharmaceutical Pricing and Reimbursement in Oncology - Payer Pressure to Justify Premium Pricing of Novel Agents, Pushing Companies to Risk-Sharing Modalities
7/10/2012 | published by: GBI Research
... “Pharmaceutical Pricing and Reimbursement in Oncology - Payer Pressure to Justify Premium Pricing of Novel Agents, Pushing Companies to Risk-Sharing Modalities”. It provides a comprehensive overview of the healthcare system, and the pricing and reimbursement ...  |  read more...
USD 3,500
Novel Therapies in Oncology - Protein Kinase Inhibitors, Monoclonal Antibodies and Vaccines Therapeutic Classes Dominate Late-Stage Pipeline
7/10/2012 | published by: GBI Research
... Protein Kinase Inhibitors, Monoclonal Antibodies and Vaccines Therapeutic Classes Dominate Late-Stage Pipeline” which provides insights into the global oncology pipeline. The report is built using data and information sourced from proprietary databases, primary and secondary ...  |  read more...
USD 3,500
Protein and Peptide-based Therapeutics - Trends in Drug Discovery and Development
7/10/2012 | published by: GBI Research
... Development. Over the last decade, protein and peptide-based therapeutics have attracted more and more attention in the pharmaceutical industry. These types of molecules exert a high level of specificity on their respective molecular targets, making ...  |  read more...
USD 3,500
Multi-Targeted Therapies - New Wave of Combination Therapies in Late Stage Development for Lung Cancer Offer Promise
7/10/2012 | published by: GBI Research
... of Combination Therapies in Late Stage Development for Lung Cancer Offer Promise”, which provides an overview of the discovery and development of therapeutic drug combinations and multi-target drugs for oncology. The report is built using ...  |  read more...
USD 3,500
Pharmaceutical Supply Chain in Europe - Adoption of Direct to Pharmacy (DTP) Model to Boost Efficiency and Optimize Pricing
7/10/2012 | published by: GBI Research
... Chain in Europe - Adoption of Direct to Pharmacy (DTP) Model to Boost Efficiency and Optimize Pricing”. The report focuses on the current scenario of supply chain management. Key participants in the pharmaceutical supply chain ...  |  read more...
USD 3,500
Biobanks - 2012 Year Book
7/10/2012 | published by: GBI Research
... major biobanks. The report provides information on population-based biobanks, disease based biobanks, brain biobanks, stem cell biobanking, twin registries, children biobanks and many national biobanks. It also provides comprehensive analysis of funding, harmonization, the cost ...  |  read more...
USD 3,500
Biobetters in Key Markets - Opportunities for Biotechnology Companies to Sustain Innovation with Low Risk and High Value Offerings
7/10/2012 | published by: GBI Research
... Key Markets - Opportunities for Biotechnology Companies to Sustain Innovation with Low Risk and High Value Offerings”, which provides insights into the impact of biobetter therapies on the top selling biologic therapeutics, the regulatory procedure ...  |  read more...
USD 3,500
Direct to Consumer (DTC) Advertising in Pharmaceuticals - Shift from Traditional Mass-Media Platforms towards Personalization via Online and Social Media
7/10/2012 | published by: GBI Research
... Consumer (DTC) Advertising in Pharmaceuticals - Shift from Traditional Mass-Media Platforms towards Personalization via Online and Social Media”, which provides insights into the up-and-coming trends of DTC advertising in the US and of awareness campaigns ...  |  read more...
USD 3,500
Biosimilars in Developed Countries - Launch of Biosimilar mAbs in Europe and New Regulatory Pathways in the US to Spur Market Growth
7/10/2012 | published by: GBI Research
... “Biosimilars in Developed Countries - Launch of Biosimilar mAbs in Europe and New Regulatory Pathways in the US to Spur Market Growth” that provides key data, information and analysis of the major trends and issues ...  |  read more...
USD 3,500
Emerging Pharmaceutical Market in Brazil - Regulatory Framework Forces MNCs to Partner with Local Players Resulting in Profit and Control Sharing
7/1/2012 | published by: GBI Research
... MNCs to Partner with Local Players Resulting in Profit and Control Sharing” provides an in-depth analysis of the trends, issues and challenges in the pharmaceutical market in Brazil. The report analyzes the overall pharmaceutical and ...  |  read more...
USD 3,500
Wound Care Management Market to 2018 - Advanced Wound Care Modalities and an Expanding Patient Base Create Significant Growth Opportunities in Emerging Countries
6/30/2012 | published by: GBI Research
... Wound Care Modalities and an Expanding Patient Base Create Significant Growth Opportunities in Emerging Countries” provides key data, information and analysis on the global wound care management market. The report provides a market landscape, competitive ...  |  read more...
USD 3,500
Gene Therapy Market to 2018 - Product Development Slowed by Clinical Failures, Close Regulatory Surveillance and High Compliance Standards
6/25/2012 | published by: GBI Research
... Failures, Close Regulatory Surveillance and High Compliance Standards”, provides in-depth analysis of the unmet needs, drivers and barriers that impact the global gene therapy market. The report analyzes technological aspects, advantages and disadvantages of various ...  |  read more...
USD 3,500
Pharmaceutical Supply Chain in the US - Advances in RFID and ePedigree Systems to Limit Drug Counterfeits
6/25/2012 | published by: GBI Research
... US - Advances in RFID and ePedigree Systems to Limit Drug Counterfeits”. It analyzes the overall Supply Chain Management (SCM) scenario and provides profiles of the leading participants in the pharmaceutical supply chain in the ...  |  read more...
USD 3,500
Endpoints - Clinical Trials in Respiratory Diseases - Pulmonary Function Tests, Biomarkers and Quality of Life Questionnaires All Play Prominent Roles
6/25/2012 | published by: GBI Research
... Pulmonary Function Tests, Biomarkers and Quality of Life Questionnaires All Play Prominent Roles” presents the use of endpoints or outcomes measures in respiratory disease’s clinical trials. In this report, endpoint used in asthma, cystic fibrosis, ...  |  read more...
USD 3,500
Emerging Pharmaceutical Market in Argentina - Domestic Pharmaceutical Companies Dominate the Market with More Than 55% of the Industry Revenue
6/25/2012 | published by: GBI Research
... the Market with More Than 55% of the Industry Revenue” provides in-depth analysis of trends, issues and challenges in the pharmaceutical market in Argentina. The report analyzes the overall pharma and clinical trials market in ...  |  read more...
USD 3,500
Generics in the Antivirals Market to 2018 - Launch of Generic Combivir and Patent Expiry of Sustiva, Kaletra and Epivir-HBV will Drive Volume Growth
6/25/2012 | published by: GBI Research
... Market to 2018 - Launch of Generic Combivir and Patent Expiry of Sustiva, Kaletra and Epivir-HBV will Drive Volume Growth” describes generic market in antiviral therapeutics. This report covers antiviral therapeutics including HIV therapeutics, Hepatitis ...  |  read more...
USD 3,500
Biosimilars in Emerging Economies - Advanced Recombinant Technology Platforms and Low Cost Manufacturing Put India and China at a Strategic Advantage in Biosimilar Production
6/25/2012 | published by: GBI Research
... latest report, “Biosimilars in Emerging Economies - Advanced Recombinant Technology Platforms and Low Cost Manufacturing Put India and China at a Strategic Advantage in Biosimilar Production” that provides key data, information and analysis of the ...  |  read more...
USD 3,500
2  3  4  5    7    9  10  11  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!